Crocin inhibits the activation of mouse hepatic stellate cells via the lnc-LFAR1/MTF-1/GDNF pathway

References

• Li J, Wang Y, Ma M, et al. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-beta signaling. EBioMedicine. 2019;40:43–55.
   PubMed Web of Science ®Google Scholar
• Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830–841.
   PubMed Web of Science ®Google Scholar
• Trautwein C, Friedman SL, Schuppan D, et al. Hepatic fibrosis: concept to treatment. J Hepatol. 2015;62:S15–24.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Ashfaq-Khan M, Yang AT, et al. Liver fibrosis: direct antifibrotic agents and targeted therapies. Matrix Biol. 2018;68-69:435–451.
   PubMed Web of Science ®Google Scholar
• Algandaby MM. Antifibrotic effects of crocin on thioacetamide-induced liver fibrosis in mice. Saudi J Biol Sci. 2018;25:747–754.
   PubMed Web of Science ®Google Scholar
• Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473–1492.
   PubMed Web of Science ®Google Scholar
• Mederacke I, Hsu CC, Troeger JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823.
   PubMed Web of Science ®Google Scholar
• Liu X, Xu J, Rosenthal S, et al. Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution. Gastroenterology. 2020;158:1728-1744.
   Web of Science ®Google Scholar
• Liao X, Zhan W, Tian T, et al. MicroRNA-326 attenuates hepatic stellate cell activation and liver fibrosis by inhibiting TLR4 signaling. J Cell Biochem. 2019.
   Web of Science ®Google Scholar
• Lapchak PA, Gash DM, Jiao S, et al. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson’s disease. Exp Neurol. 1997;144:29–34.
   PubMed Web of Science ®Google Scholar
• Ayanlaja AA, Zhang B, Ji G, et al. The reversible effects of glial cell line-derived neurotrophic factor (GDNF) in the human brain. Semin Cancer Biol. 2018;53:212–222.
   PubMed Web of Science ®Google Scholar
• Grondin R, Littrell OM, Zhang Z, et al. GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution. Neuropharmacology. 2019;147:28–36.
   PubMed Web of Science ®Google Scholar
• Tao L, Ma W, Wu L, et al. Glial cell line-derived neurotrophic factor (GDNF) mediates hepatic stellate cell activation via ALK5/Smad signalling. Gut. 2019;68:2214–2227.
   PubMed Web of Science ®Google Scholar
• Yu F, Geng W, Dong P, et al. LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212. Cell Death Dis. 2018;9:1014.
   PubMed Web of Science ®Google Scholar
• Yu F, Jiang Z, Chen B, et al. NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6. J Mol Med (Berl). 2017;95:1191–1202.
   PubMed Web of Science ®Google Scholar
• Donato L, Scimone C, Alibrandi S, et al. Transcriptome analyses of lncRNAs in A2E-stressed retinal epithelial cells unveil advanced links between metabolic impairments related to oxidative stress and retinitis pigmentosa. Antioxidants (Basel). 2020;9:318.
   Google Scholar
• Haroon ZA, Amin K, Lichtlen P, et al. Loss of metal transcription factor-1 suppresses tumor growth through enhanced matrix deposition. Faseb J. 2004;18:1176–1184.
   PubMed Web of Science ®Google Scholar
• Zhang K, Han X, Zhang Z, et al. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFbeta and Notch pathways. Nat Commun. 2017;8:144.
   PubMed Web of Science ®Google Scholar
• Feng J, Wang C, Liu T, et al. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis. J Cell Mol Med. 2019;23:6479–6493.
   PubMed Web of Science ®Google Scholar
• Liu XD, Wu JL, Liang J, et al. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients. World J Gastroenterol. 2012;18:2784–2792.
   PubMed Web of Science ®Google Scholar
• Nguyen-Lefebvre AT, Ajith A, Portik-Dobos V, et al. The innate immune receptor TREM-1 promotes liver injury and fibrosis. J Clin Invest. 2018;128:4870–4883.
   PubMed Web of Science ®Google Scholar
• Donato L, Scimone C, Rinaldi C, et al. Stargardt phenotype associated with two ELOVL4 promoter variants and ELOVL4 downregulation: new possible perspective to etiopathogenesis? Invest Ophthalmol Vis Sci. 2018;59:843–857.
   PubMed Web of Science ®Google Scholar
• Zhang D, Song XJ, Li SY, et al. Evaluation of liver function and electroacupuncture efficacy of animals with alcoholic liver injury by the novel imaging methods. Sci Rep. 2016;6:30119.
   PubMed Web of Science ®Google Scholar
• Arakawa Y, Amaki S, Miyakawa H, et al. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto’s disease with positivity for anti-centromere antibody. J Gastroenterol. 2004;39:490–495.
   PubMed Web of Science ®Google Scholar
• Carnicella S, Ron D. GDNF–a potential target to treat addiction. Pharmacol Ther. 2009;122:9–18.
   PubMed Web of Science ®Google Scholar
• Donnelly CR, Shah AA, Mistretta CM, et al. Biphasic functions for the GDNF-Ret signaling pathway in chemosensory neuron development and diversification. Proc Natl Acad Sci U S A. 2018;115:E516–e525.
   PubMed Web of Science ®Google Scholar
• Nencini S, Ringuet M, Kim DH, et al. GDNF, neurturin, and artemin activate and sensitize bone afferent neurons and contribute to inflammatory bone pain. J Neurosci. 2018;38:4899–4911.
   PubMed Web of Science ®Google Scholar
• Garcia TX, Parekh P, Gandhi P, et al. The NOTCH Ligand JAG1 regulates gdnf expression in sertoli cells. Stem Cells Dev. 2017;26:585–598.
   PubMed Web of Science ®Google Scholar
• Brodbeck S, Besenbeck B, Englert C. The transcription factor Six2 activates expression of the Gdnf gene as well as its own promoter. Mech Dev. 2004;121:1211–1222.
   PubMed Web of Science ®Google Scholar
• Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152:1298–1307.
   PubMed Web of Science ®Google Scholar
• Yu F, Chen B, Dong P, et al. PTEN expression via MicroRNA-29b: a novel mechanism in regulation of liver fibrosis. Mol Ther. 2017;25:205–217.
   PubMed Web of Science ®Google Scholar
• Zhang K, Han Y, Hu Z, et al. SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker. Theranostics. 2019;9:3622–3638.
   PubMed Web of Science ®Google Scholar
• Donato L, D’Angelo R, Alibrandi S, et al. Effects of A2E-induced oxidative stress on retinal epithelial cells: new insights on differential gene response and retinal dystrophies. Antioxidants. 2020;9:307.
   Web of Science ®Google Scholar
• Donato L, Scimone C. Discovery of GLO1 new related genes and pathways by RNA-Seq on A2E-stressed retinal epithelial cells could improve knowledge on retinitis pigmentosa. Antioxidants. 2020;9:416.
   Web of Science ®Google Scholar
• Rinaldi C, Bramanti P, Scimone C, et al. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations. J Neurol Sci. 2017;380:31–37.
   PubMed Web of Science ®Google Scholar
• Scimone C, Donato L, Katsarou Z, et al. Two novel KRIT1 and CCM2 mutations in patients affected by cerebral cavernous malformations: new information on CCM2 penetrance. Front Neurol. 2018;9:953.
   PubMed Web of Science ®Google Scholar